| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
NXGL Stock Overview
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels.
NEXGEL, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.86 |
| 52 Week High | US$4.66 |
| 52 Week Low | US$1.36 |
| Beta | 0 |
| 1 Month Change | 4.31% |
| 3 Month Change | 25.68% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -72.77% |
Recent News & Updates
Shareholder Returns
| NXGL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -6.1% | 2.3% | 3.6% |
| 1Y | n/a | -19.6% | -9.6% |
Return vs Industry: Insufficient data to determine how NXGL performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how NXGL performed against the US Market.
Price Volatility
| NXGL volatility | |
|---|---|
| NXGL Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 9.4% |
| Market Average Movement | 7.7% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: NXGL is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: NXGL's weekly volatility has decreased from 14% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 10 | Adam Levy | https://nexgel.com |
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019.
NEXGEL, Inc. Fundamentals Summary
| NXGL fundamental statistics | |
|---|---|
| Market Cap | US$10.36m |
| Earnings (TTM) | -US$5.65m |
| Revenue (TTM) | US$1.82m |
5.7x
P/S Ratio-1.8x
P/E RatioIs NXGL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXGL income statement (TTM) | |
|---|---|
| Revenue | US$1.82m |
| Cost of Revenue | US$1.70m |
| Gross Profit | US$120.00k |
| Other Expenses | US$5.77m |
| Earnings | -US$5.65m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.01 |
| Gross Margin | 6.58% |
| Net Profit Margin | -309.87% |
| Debt/Equity Ratio | 16.3% |
How did NXGL perform over the long term?
See historical performance and comparison